What Researchers Did
Researchers conducted a pilot study with 24 adult type 1 diabetes mellitus patients experiencing peripheral vascular complications to assess the effects of 10 hyperbaric oxygen therapy sessions on plasma fatty acid composition and insulin-like growth factor binding protein 1 expression.
What They Found
They found that hyperbaric oxygen therapy significantly decreased total cholesterol, triglycerides, and low-density lipoprotein (all p<0.05). It also increased plasma levels of individual fatty acids like palmitic acid (p<0.05) and docosahexaenoic acid (p<0.01), while decreasing others, and increased IGFBP-1 (p<0.01) while decreasing insulin (p<0.001).
What This Means for Canadian Patients
This pilot study suggests that hyperbaric oxygen therapy could potentially improve metabolic markers and fatty acid profiles in patients with type 1 diabetes and vascular complications. Such improvements might contribute to better management of cardiovascular risk factors associated with the disease.
Canadian Relevance
Although published in a Canadian journal, this pilot study itself does not have a direct Canadian connection or involve Canadian participants.
Study Limitations
A key limitation of this study is its small sample size of 24 patients and its pilot nature, which limits the generalizability of the findings.